Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Theramex SafiledCriticalLaboratoire Theramex Sa
Priority to MYPI93002555ApriorityCriticalpatent/MY109207A/en
Publication of MY109207ApublicationCriticalpatent/MY109207A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicinal Preparation
(AREA)
Abstract
THIS PATENT APPLICATION RELATES TO THE FIELD OF MEDICINAL CHEMISTRY AND MORE PARTICULARLY, TO THAT OF PHARMACOTECHNOLOGY. IT HAS MORE PARTICULARLY AS A SUBJECT MATTER NOVEL COMPOSITIONS ADAPTED TO THE LOCAL WAY AND MORE PRECISELY TO FORMULATIONS INTENDED TO BE INSERTED INTO THE SUBCUTANEOUS TISSUES AND COMMONLY SO-CALLED IMPLANTS. THESE IMPLANTS ARE OF VARIOUS NATURES (HYDROPHOBIC, HYDROPHILIC, BIODEGRADABLE) AND OF VARIOUS KINDS (CONTAINER, MATRIX). THESE IMPLANTS INCLUDE AN EFFICIENT AMOUNT OF A 3,20-DIOXO 6-METHYL 17(ALPHA)-ACETOXY 19-NOR PREGNA 4,6-DIEN DERIVATIVE OPTIONALLY SUBSTITUTED IN POSITION 3 AND/OR IN POSITION 17 (ALPHA) , IN ADMIXTURE OR CONJUNCTION WITH AN INERT BIOLOGICALLY -ACCEPTABLE CARRIER. THE THUS, PRODUCED IMPLANTS ARE EFFICIENT CONTRACEPTIVE AGENTS AND HAVING A DURATION OF ACTIVITY OF AT LEAST ONE YEAR WITH THE MINIMUM OF SIDE-EFFECTS.
MYPI93002555A1993-12-021993-12-02Subcutaneous implants based on nomegestrol derivatives
MY109207A
(en)